NCT03313843View on ClinicalTrials.gov

Study to Assess OCT: RNFL and GCL in MS Patients

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

February 9, 2018

Primary Completion Date

December 17, 2020

Study Completion Date

April 30, 2021

Conditions
Multiple Sclerosis
Trial Locations (2)

33618

Tampa Bay Uveitis Center, Tampa

34655

Tampa Bay Uveitis Center, New Port Richey

All Listed Sponsors
lead

Tampa Bay Uveitis Center, LLC

OTHER

NCT03313843 - Study to Assess OCT: RNFL and GCL in MS Patients | Biotech Hunter | Biotech Hunter